Skip to content

Alzheimer's Disease Genetics Study

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00064870
Acronym
NCRAD
Enrollment
10000
Registered
2003-07-16
Start date
2002-06-01
Completion date
2031-08-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Dementia, Late Onset Alzheimer Disease

Keywords

Alzheimer disease, Late Onset Alzheimer disease risk factor genes, Genetics, Initiative, Dementia

Brief summary

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Detailed description

The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from families with multiple members diagnosed with AD. Qualifying families will have two living blood-related individuals who have been diagnosed with or are showing symptoms of AD or dementia. Local study sites are located all over the United States, and arrangements may be made for eligible families who do not live near a participating site. The biological samples and data from these families will be made available to qualified researchers, who must sign a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study participants before receiving samples and data.

Interventions

None listed

Sponsors

Indiana University
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Two living family members diagnosed with AD or other dementia with any age of onset * Biological samples available * Fresh blood, or * Immortalized lymphoblastic cell lines, or * 3-5 grams of frozen cerebral cortex; fixed samples are not accepted Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.

Exclusion criteria

* Does not meet inclusion criteria * Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection

Design outcomes

Primary

MeasureTime frameDescription
Distribute biological specimens to qualified investigators for use in their research studies.Contact investigators annually for an update on progress and publication status.Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.

Countries

United States

Contacts

CONTACTStudy Coordinator
alzstudy@iu.edu1-800-526-2839
PRINCIPAL_INVESTIGATORTatiana M. Foroud, PhD

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026